SCHEMBL2924009

SCHEMBL2924009

C/C=C(/F)COc1ccc(Cl)cc1Cl

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.58
TSHR P16473 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.52
ALDH1A1 P00352 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
POLB P06746 1/20 0.49
HTT P42858 1/20 0.49
MAPT P10636 3/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
ALOX12 P18054 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915967 0.83 AOC3 (0.61) TDP1TSHRSMN1; SMN2HTTMAPT
SCHEMBL2915970 0.83 AOC3 (0.61) TDP1TSHRSMN1; SMN2HTTMAPT
SCHEMBL2915961 0.83 AOC3 (0.61) TDP1TSHRSMN1; SMN2HTTMAPT
Hydrochloric Acid SCHEMBL2923259 0.81 AOC3 (0.59) TDP1TSHRSMN1; SMN2HTTMAPT
SCHEMBL2922246 0.81 CYP2C19 (0.65) TDP1TSHRSMN1; SMN2ALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL2923262 0.81 AOC3 (0.59) TDP1TSHRSMN1; SMN2HTTMAPT
Hydrochloric Acid SCHEMBL2923263 0.81 AOC3 (0.59) TDP1TSHRSMN1; SMN2HTTMAPT
2,4-Dichlorophenoxyacetic Acid SCHEMBL19462973 0.78 TDP1 (0.84) TDP1TSHRSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL22591956 0.76 TDP1 (0.62) TDP1TSHRSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL9974137 0.76 TDP1 (0.72) TDP1TSHRSMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222160-A2 HALOALLYLAMINE INHIBITORS OF SSAO/VAP-1 AND USES THEREFOR Pharmaxis Ltd. (AU) 2010-09-01 EP disclosed
WO-2009066152-A2 HALOALLYLAMINE INHIBITORS OF SSAO/VAP-1 AND USES THEREFOR PHARMAXIS LTD. (US) 2009-05-28 WO disclosed